A new class of COX-2 inhibitor, rutaecarpine from Evodia rutaecarpa

Inflammation Research

Volumn 48, Issue 12, 1999, Pages 621-625

  Moon, T C ^a   Murakami, M ^b   Kudo, I ^b   Son, K H ^c   Kim, H P ^d   Kang, S S ^e   Chang, H W ^a  

^a Yeungnam University   (South Korea)

^b SHOWA UNIVERSITY   (Japan)

^c Andong National University   (South Korea)

^d Kangwon National University   (South Korea)

^e Seoul National University   (South Korea)

Author keywords

Anti inflammation; Bone marrow derived mast cells (BMMC); Cyclooxygenase 2 inhibitor; Evodia rutaecarpa; Rutaecarpine

Indexed keywords

ARACHIDONIC ACID; CARRAGEENAN; CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; EVODIA FRUIT; INTERLEUKIN 10; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN E2; ROFECOXIB; RUTAECARPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ISOLATION; DRUG STRUCTURE; ENZYME INHIBITION; FEMALE; FRUIT; HUMAN; HUMAN CELL; MAST CELL; NONHUMAN; PAW EDEMA; PHYTOCHEMISTRY; RAT;

ALKALOIDS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL LINE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FRUIT; HUMANS; IMMUNOBLOTTING; INFLAMMATION; ISOENZYMES; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; PLANT EXTRACTS; PLANTS, MEDICINAL; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, SPRAGUE-DAWLEY; TRANSFECTION;

EID: 0033401423     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050512     Document Type: Article

References (22)

1. [1] Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 1971; 231: 232-5.
2. [2] Whittle BJR, Higgs GA, Eakins KE, Moncada S, Vane JR. Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa. Nature (Lond) 1980; 284: 271-3.
3. [3] Maier JA, Hla T, Maciag T. Cyclooxygenase is an immediate-early gene induced by interleukin-1 in human endothelial cells. J Biol Chem 1990; 265: 10805-8.
4. [4] O'Banion MK, Winn VD, Young DA. cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc Natl Acad Sci USA 1992; 89: 4888-92.
5. [5] DeWitt DL, Smith WL. Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence. Proc Natl Acad Sci USA 1988; 85: 1412-6.
6. [6] Smith WL, Garavito RM, DeWitt DL. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 1996; 271: 33157 60.
7. [7] Griswold DE, Adams JL. Constitutive cyclooxygenase (COX-1) and inducible cyclooxygenase (COX-2): rationale for selective inhibition and progress to date. Med Res Rev 1996; 16: 181 206.
8. [8] Futaki N, Takahashi S, Yokoyama M, Arai I, Higuchi S, Otomo S. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 1994; 47: 55-9.
9. [9] Prasit P, Wang Z, Brideau C, Chan CC, Charleson S, Cromlish W, et al. The discovery of rofecoxib, [MK 966, Vioxx, 4-(4′-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2-inhibitor. Bioorg Med Chem Lett 1999; 9(13): 1773-8.
10. [10] Geis GS. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect? J Rheumatol Rev 1999; 56: 31-3.
11. [11] Moon TC, Chung KC, Son KH, Kim HP, Kang SS, Chang HW. Screening of cyclooxygenase-2 (COX-2) inhibitors from natural products. Yakhak Hoiji 1998; 42: 214-9.
12. [12] Moon TC, Murakami M, Ashraf MDM, Kudo I, Chang HW. Regulation of cyclooxygenase-2 and endogenous cytokine expression by bacterial lipopolysaccharide that acts in synergy with c-kit ligand and Fc ε receptor I crosslinking in cultured mast cell. Cell Immnunol 1998; 185: 146-52.
13. 2 in mouse bone marrow-derived mast cells. J Biol Chem 1994; 269: 22269-75.
14. [14] Park CH, Kim S-H, Choi H, Lee Y-J, Kim JS, Kang SS, et al. Novel anticholinesterase and antiamnesic activities of dehydroevodiamine, a constituent of Evodia rutaecarpa. Planta Med 1996; 62: 405-9.
15. 2 and 5-lipoxygenase. J Exp Med 1995; 182: 197-206.
16. 2 generation via prostaglandin endoperoxide synthase-2. J Immunol 1995; 155:4445-53.
17. 2s and cyclooxygenases in immediate and delayed prostanoid biosynthetic pathways. J Biol Chem 1999; 274: 3103-15.
18. [18] Winter CA, Risley EA, Nuss GW. Carrgeenan-induced edema in the hindpaw of the rat as an assay for anti-inflammatory drugs. Proc Soc Exp Biol Med 1962; 111: 544-7.
19. 2 from cytosol to the nuclear envelope in rat basophilic leukemia cells stimulated with calcium ionophore or IgE/antigen. J Biol Chem 1995; 270: 15359-67.
20. 2 generation in mouse bone marrow-derived mast cells. J Biol Chem 1996; 271: 25936-44.
21. [21] Chiou WF, Liao JP, Chen CF. Comparative study of the vasodilatory effects of three quinazoline alkaloids isolated from Evodia rutaecarpa. J Nat Prod 1996; 59: 374-8.
22. [22] Matsuda H, Yoshikawa M, Iinuma M, Kubo M. Antinociceptive and anti-inflammatory activities of limonin isolated from the fruits of Evodia rutaecarpa var. bodinieri. Planta Med 1998; 64: 339-42.